Women may experience more chronic pain due to differences in their immune responses and higher levels of leptin. This ...

Researchers at the University of Calgary have uncovered biological differences between the sexes in how chronic pain is ...

A peculiarity of this numbness is that it may be accompanied by intractable pain. This type of pain, resulting from damage to ...

MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA), a clinical-stage pharmaceutical company developing breakthrough therapeutics for neurologic and neuropsychiatric disorders, today announced the enrollment of ...

Neuropathic pain affects up to 10 percent of the global population and can be challenging to manage effectively with existing medications. As a possible alternative treatment option, scientists at ...

"This research provides compelling preclinical evidence that tsFUS could offer a safe and effective approach for managing neuropathic pain," said Dr. Zanos. "By targeting the spinal cord directly ...

This important clinical milestone follows compelling preclinical data, where Ketamir-2 demonstrated superior efficacy compared to FDA-approved neuropathic pain treatments, including pregabalin and ...

Urcosimod in Phase 2 clinical trial for Neuropathic Corneal Pain shown to have Long-Term StabilityUrcosimod stable in single-use ampoules for ...

MIRA Pharmaceuticals (MIRA) announced the enrollment of the first subjects in its Phase 1 clinical trial of Ketamir-2, a novel oral ketamine ...